0.1058  -0.023 (-17.98%)		04-23 12:41
Open: 0.1214 High: 0.13 Volume: 66,315,002		Pre. Close: 0.129 Low: 0.0987 Market Cap: 1(M)

Short term
Mid term
Targets	6-month :	0.19	1-year :	0.24
Resists	First :	0.16	Second :	0.21
Pivot price	0.14
Supports	First :	0.09	Second :	0.08
MAs	MA(5) :	0.12	MA(20) :	0.14
	MA(100) :	0.21	MA(250) :	0
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	15.6	D(3) :	19.4
RSI	RSI(14): 35.1
52-week	High :	2.23	Low :	0.09

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ MEHA ] has closed above bottom band by 13.3%. Bollinger Bands are 3.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	0.13 - 0.13	0.13 - 0.14
Low:	0.12 - 0.12	0.12 - 0.12
Close:	0.13 - 0.13	0.13 - 0.13

The company manufactures and distributes nutraceutical supplements in the U.S., covering categories such as pain, energy, prenatal, general health, bone & joint, gastro, immunity, cardiac, detox, brain & memory, sleep, and urinary. It also offers hemp-derived products including capsules, gummies and tinctures.

Thu, 23 Apr 2026
Functional Brands (MEHA) Stock Outlook | Functional Brands Inc. posts $0.01 EPS, $6.6M revenue no estimates - Investor Call - Xã Vĩnh Công

Wed, 22 Apr 2026
Functional Brands (MEHA) Stock Outlook | Functional Brands Inc. posts $0.01 EPS, $6.6M revenue no estimates - Dividend Yield - Xã Thanh Hà

Mon, 20 Apr 2026
Functional Brands (MEHA) Stock: Long-Term Outlook Review (Investors Pile In) 2026-04-20 - Social Buzz Stocks - Xã Thanh Hà

Tue, 14 Apr 2026
These stocks are moving in today's session - ChartMill

Mon, 30 Mar 2026
Functional Brands Announces Fourth Quarter and Full-Year 2025 Financial Results - Yahoo Finance

Mon, 30 Mar 2026
Revenue slipped, but Functional Brands turned a Q4 loss into profit - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Outperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Outperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Distribution
Shares Out	21 (M)
Shares Float	19 (M)
Held by Insiders	4.2 (%)
Held by Institutions	2.1 (%)
Shares Short	477 (K)
Shares Short P.Month	260 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0.07
Profit Margin	11.4 %
Operating Margin	-75.8 %
Return on Assets (ttm)	-10.8 %
Return on Equity (ttm)	106.6 %
Qtrly Rev. Growth	-11 %
Gross Profit (p.s.)	0.16
Sales Per Share	0.31
EBITDA (p.s.)	-0.07
Qtrly Earnings Growth	0 %
Operating Cash Flow	-1 (M)
Levered Free Cash Flow	1 (M)

PE Ratio	10.77
PEG Ratio	0
Price to Book value	1.34
Price to Sales	0.33
Price to Cash Flow	-1.77

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.